Dec 19, 2022
A derivative of the family of natural products called schweinfurthins uniquely induce cancer cell death, according to a Penn State College of Medicine and Penn State Cancer Institute research study.
Dec 13, 2022
A study by Penn State College of Medicine researchers found that nearby hospitals see increased emergency department visits and admissions as a result of rural hospital closures.
Dec 8, 2022
Penn State Clinical and Translational Science Institute (CTSI) invites applications for pilot projects designed to build connections across the translational spectrum of the health and biomedical sciences.
Dec 7, 2022
Penn State researchers co-led a study that identified more than 2,300 genes predicting alcohol and tobacco use. They found many of these genes were similar among people with diverse ancestries.
Dec 5, 2022
A saliva-based test that rapidly and accurately diagnoses concussions is expected to be available to physicians in 2023 following a patent awarded to Penn State and partners.
Dec 2, 2022
Penn State Clinical and Translational Science Institute's Implementation Science Core seeks to improve health equity, by increasing the adoption, integration and sustainability of evidence-based practices into real-world settings.
Dec 1, 2022
Penn State Addiction Center for Translation will host the Eighth Annual Penn State Addiction Symposium on Dec. 6, from 9 a.m.-3:30 p.m.
Nov 28, 2022
Penn State Cancer Institute researcher Dr. Monali Vasekar has received the Robert A. Winn Diversity in Clinical Trials Career Development Award from the Bristol Myers Squibb Foundation.
Nov 21, 2022
Between July and September 2022, College of Medicine researchers received 177 grants and contracts totaling $49.9 million for research.
Nov 15, 2022
A new study by Penn State College of Medicine finds that small molecules found in most humans’ breast milk may reduce the likelihood of infants developing allergic conditions.
